These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor. Matsuo T; Kario K; Chikahira Y; Nakao K; Yamada T Br J Haematol; 1992 Nov; 82(3):627-9. PubMed ID: 1486048 [No Abstract] [Full Text] [Related]
7. Anticoagulant therapy with MD805 of a hemodialysis patient with heparin-induced thrombocytopenia. Matsuo T; Yamada T; Yamanashi T; Ryo R Thromb Res; 1990 Jun; 58(6):663-6. PubMed ID: 2385832 [No Abstract] [Full Text] [Related]
8. Heparin-induced thrombocytopenia with aortoiliac thrombosis treated with argatroban. Alarcón Pérez L; Rodríguez Huerta AM; Duque González P Med Clin (Barc); 2017 Mar; 148(6):286-287. PubMed ID: 28131516 [No Abstract] [Full Text] [Related]
9. An overview of heparin-induced thrombocytopenia. Donovan JL; Tran MT; Kanaan AO J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818 [TBL] [Abstract][Full Text] [Related]
10. Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia. Suzuki S; Sakamoto S; Koide M; Matsuo M; Fujii K; Matsuo T Thromb Res; 1997 Dec; 88(6):499-502. PubMed ID: 9610961 [No Abstract] [Full Text] [Related]
11. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Lewis BE; Walenga JM; Wallis DE Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347 [TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia in haemodialysis treated with argatroban. Quiñones-Ortiz L; Suárez-Laurés A; Pablos-de Pablo M; Robles V; Calzón-Blanco C; Quiñones-Pérez S; Ayausty-Ruiz A Nefrologia; 2014; 34(5):670-4. PubMed ID: 25036261 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban. Hourmouzis Z; Bhalla MC; Frey JA; Jwayyed S Am J Emerg Med; 2015 May; 33(5):739.e5-6. PubMed ID: 25497698 [No Abstract] [Full Text] [Related]
17. Direct thrombin inhibitors in heparin-induced thrombocytopenia. Verme-Gibboney C; Dubb JW Am J Health Syst Pharm; 2005 Feb; 62(3):247-8; author reply 248, 250. PubMed ID: 15719581 [No Abstract] [Full Text] [Related]
18. Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia. Gilmore JF; Adams CD; Blum RM; Fanikos J; Anne Hirning B; Matta L Am J Hematol; 2015 Aug; 90(8):E143-5. PubMed ID: 25913754 [No Abstract] [Full Text] [Related]
19. [Diagnosis and treatment of heparin-induced thrombocytopenia]. Link A; Pöss J; Böhm M Dtsch Med Wochenschr; 2011 May; 136(18):953-62; quiz 963-6. PubMed ID: 21526460 [No Abstract] [Full Text] [Related]
20. The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report. Lewis BE; Rangel Y; Fareed J Angiology; 1998 Jan; 49(1):61-7. PubMed ID: 9456166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]